BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10394132)

  • 21. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus.
    Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA
    Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia.
    Rossi E; Matutes E; Morilla R; Owusu-Ankomah K; Heffernan AM; Catovsky D
    Leukemia; 1996 Mar; 10(3):494-7. PubMed ID: 8642868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-localization of Fyn with CD3 complex, CD45 or CD28 depends on different mechanisms.
    zur Hausen JD; Burn P; Amrein KE
    Eur J Immunol; 1997 Oct; 27(10):2643-9. PubMed ID: 9368621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
    Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
    Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.
    Hutchcroft JE; Slavik JM; Lin H; Watanabe T; Bierer BE
    J Immunol; 1998 Nov; 161(9):4506-12. PubMed ID: 9794375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells.
    Soto-Peña GA; Vega L
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):216-26. PubMed ID: 18407307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced Cbl phosphorylation and degradation of the zeta-chain of the T-cell receptor/CD3 complex in T cells with low Lck levels.
    Methi T; Berge T; Torgersen KM; Taskén K
    Eur J Immunol; 2008 Sep; 38(9):2557-63. PubMed ID: 18792408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD3 zeta expression of regional lymph node and peripheral blood lymphocytes in gastric cancer.
    Ishigami S; Natsugoe S; Miyazono F; Tokuda K; Nakajo A; Matsumoto M; Okumura H; Nakashima S; Hokita S; Maruyama I; Aikou T
    Anticancer Res; 2004; 24(3b):2123-6. PubMed ID: 15274412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules.
    Cemerski S; van Meerwijk JP; Romagnoli P
    Eur J Immunol; 2003 Aug; 33(8):2178-85. PubMed ID: 12884292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of CD28, TCR-zeta (zeta) and up-regulation of FAS in peripheral cytotoxic T-cells of primary breast cancer patients.
    Gruber IV; El Yousfi S; Dürr-Störzer S; Wallwiener D; Solomayer EF; Fehm T
    Anticancer Res; 2008; 28(2A):779-84. PubMed ID: 18507020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection.
    Seitzer U; Kayser K; Höhn H; Entzian P; Wacker HH; Ploetz S; Flad HD; Gerdes J; Maeurer MJ
    Immunology; 2001 Nov; 104(3):269-77. PubMed ID: 11722641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.
    Stefanová I; Saville MW; Peters C; Cleghorn FR; Schwartz D; Venzon DJ; Weinhold KJ; Jack N; Bartholomew C; Blattner WA; Yarchoan R; Bolen JB; Horak ID
    J Clin Invest; 1996 Sep; 98(6):1290-7. PubMed ID: 8823293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer.
    Takahashi A; Kono K; Amemiya H; Iizuka H; Fujii H; Matsumoto Y
    Clin Cancer Res; 2001 Jan; 7(1):74-80. PubMed ID: 11205921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a signaling complex involving CD2, zeta chain and p59fyn in T lymphocytes.
    Gassmann M; Amrein KE; Flint NA; Schraven B; Burn P
    Eur J Immunol; 1994 Jan; 24(1):139-44. PubMed ID: 7912674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical analysis of p120/130: a protein-tyrosine kinase substrate restricted to T and myeloid cells.
    da Silva AJ; Rosenfield JM; Mueller I; Bouton A; Hirai H; Rudd CE
    J Immunol; 1997 Mar; 158(5):2007-16. PubMed ID: 9036943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TCR subunit specificity of CTLA-4-mediated signaling.
    Siu E; Carreno BM; Madrenas J
    J Leukoc Biol; 2003 Dec; 74(6):1102-7. PubMed ID: 12972512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance.
    Salmond RJ; Filby A; Qureshi I; Caserta S; Zamoyska R
    Immunol Rev; 2009 Mar; 228(1):9-22. PubMed ID: 19290918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of T cell receptor-mediated Th1 cell IFN-gamma production and proliferation by divergent cAMP-mediated redox pathways.
    Cochrane R; Clark RB; Huang CK; Cone RE
    J Interferon Cytokine Res; 2001 Oct; 21(10):797-807. PubMed ID: 11710991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells.
    Sharma N; Akhade AS; Qadri A
    Innate Immun; 2016 Apr; 22(3):238-44. PubMed ID: 26888964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T lymphocyte activation: the role of tyrosine phosphorylation.
    Jackson DI; Verbi W; Lazarovits AI; Crumpton MJ
    Cancer Surv; 1995; 22():97-110. PubMed ID: 7720062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.